期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
印度Biocon公司进一步在胰岛素项目上投资
1
作者 城户佳织 《生物产业技术》 2012年第1期74-75,共2页
2011年4月,位于印度班加鲁尔的生物产业大型企业Biocon公司宣布,在今后的三四年内将再向胰岛素项目投资1亿美元左右。
关键词 项目投资 胰岛素 印度 大型企业 生物产业
下载PDF
Interleukin-8, a promising predictor for prognosis of pancreatic cancer 被引量:18
2
作者 Ying Chen Min Shi +4 位作者 Guan-Zhen Yu Xiao-Ran Qin Gang Jin Peng Chen Ming-Hua Zhu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第10期1123-1129,共7页
AIM: To investigate the value of interleukin-8 (IL-8), a pro-inflammatory chemokine, in predicting the prognosis of pancreatic cancer. METHODS: Expression of IL-8 and its receptor CXCR1 was assessed by immunohistochem... AIM: To investigate the value of interleukin-8 (IL-8), a pro-inflammatory chemokine, in predicting the prognosis of pancreatic cancer. METHODS: Expression of IL-8 and its receptor CXCR1 was assessed by immunohistochemistry in pancreatic cancer and chronic pancreatitis samples. Enzyme-linked immunosorbent assay was used to detect the serum IL-8 levels in pancreatic cancer patients. Human pancreatic cancer tissues were heterotopically transplanted to the immune-deficiency mice to evaluate the effect of serum IL-8 on the tumorigenesis of the cancer samples.RESULTS: IL-8 and CXCR1 proteins were both overexpressed in pancreatic adenocarcinoma samples (55.6% and 65.4%, respectively) compared with the matched para-cancer tissues (25.9% and 12.3%, P < 0.01), or chronic pancreatitis (0% and 25%, P < 0.05). Serum IL-8 levels in pancreatic cancer patients (271.1 ± 187.7 ng/mL) were higher than in other digestive system tumors, such as gastric cancer (41.77 ± 9.11 ng/mL, P = 0.025), colorectal carcinoma (78.72 ± 80.60 ng/mL, P = 0.032) and hepatocellular carcinoma (59.60 ± 19.80 ng/mL, P = 0.016). In vivo tumorigenesis analysis further proved that tumor tissues from patients with higher serum IL-8 levels grew faster than those with lower IL-8 levels. CONCLUSION: IL-8 can be a fine serum marker for predicting the prognosis pancreatic cancer. 展开更多
关键词 Pancreatic cancer INTERLEUKIN-8 CXCR1 IMMUNOHISTOCHEMISTRY Tumor implantation Enzymelinked immunosorbent assay
下载PDF
Synthesis of Monoglycerides with Cinnamomum Burmannii Seeds Oil and Its Application in Moisturizing Cream
3
作者 Zhenhao Dong Xiaoxia Zhao 《China Detergent & Cosmetics》 2016年第2期60-66,共7页
Synthesis of monoglycerides with Cinnamomum burmannii seeds oil and its application in moisturizing cream were studied. The results showed that the optimal transesterification conditions of synthesis of monoglycerides... Synthesis of monoglycerides with Cinnamomum burmannii seeds oil and its application in moisturizing cream were studied. The results showed that the optimal transesterification conditions of synthesis of monoglycerides with Cinnamomum burmannii seeds oil were as follows: the glycerol to oil molar ratio of 3 : 1 ; NaOH catalyst dosage of 0.8% of the oil mass; reaction temperature of 180 ℃ for 3 hours; and the yield reached 62.6% . The crude product was purified by molecular distillation and the purity of the final product achieved 92.8%. Physicochemical properties of moisturizing cream prepared by using the final product can meet the requirements of China National Standard and the cosmetic product displayed good performance in application. 展开更多
关键词 anionic surfactant MONOGLYCERIDES Cinnamomum burmannii seeds oil moisturizing cream
下载PDF
Drug metabolism in drug discovery and development 被引量:10
4
作者 Zhoupeng Zhang Wei Tang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2018年第5期721-732,共12页
Drug metabolism as a discipline plays an important role in drug discovery and development and the effects of drug metabolism on pharmacokinetics(PK), pharmacodynamics(PD), and safety should be carefully considered. Th... Drug metabolism as a discipline plays an important role in drug discovery and development and the effects of drug metabolism on pharmacokinetics(PK), pharmacodynamics(PD), and safety should be carefully considered. This communication provides an overview of common strategies in the area of drug metabolism for improving PK/PD and safety profiles of drug candidates; these include, but are not limited to, collaboration with medicinal chemists on structure–activity relationships(SAR) to overcome high clearance, using deuterium replacement to further optimize a lead, prodrug approaches to circumvent formulation and delivery difficulties, and addressing issues such as species differences in metabolism,drug–drug interactions(DDI) and formation of reactive metabolites. 展开更多
关键词 BIOACTIVATION DRUG discovery and development DRUG metabolism METABOLITE PHARMACOKINETICS PHARMACODYNAMICS Safety TOXICITY
原文传递
Identification of cancer stem cells provides novel tumor models for drug discovery 被引量:1
5
作者 Douglas D.Fang Danyi Wen Yajun Xu 《Frontiers of Medicine》 SCIE CSCD 2012年第2期112-121,共10页
Cancer stem cells(CSCs)have received considerable attention from the research community since they were first reported in human acute myeloid leukemia 15 years ago.Accumulating evidence suggests that CSCs are responsi... Cancer stem cells(CSCs)have received considerable attention from the research community since they were first reported in human acute myeloid leukemia 15 years ago.Accumulating evidence suggests that CSCs are responsible for tumor initiation and progression,drug resistance,and metastasis in both liquid and solid tumors.These findings lead to the development of novel compounds targeting CSC populations that is becoming increasingly important for eradicating CSCs in heterogeneous tumor masses and to cure the cancer.Since 2003,we have participated in CSC studies and encountered crucial early events in the field.This article reviews the history of CSC biology,clarifies the term and its definition,and further addresses the issue of how to utilize CSCs in therapeutic target discovery and drug development based on our substantial experience. 展开更多
关键词 cancer stem cell tumor model drug discovery
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部